HomeQuestion

Is there greater efficacy of TPO-RA in patients who have undergone a splenectomy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How would you manage ITP in patients who develop cirrhosis and hemorrhage?

How would you manage presumed gestational thrombocytopenia with moderate thrombocytopenia for delivery planning?

Do you routinely screen and replace Vitamin D in patients with ITP?

Would you offer TPO-RAs to a steroid-refractory chronic ITP patient with history of stroke?

If Ianalumab + eltrombopag (VAYHIT2) gains regulatory approval, what would make you consider its use for second line therapy after glucocorticoid failure/relapse given its potential hematologic toxicity?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

Is there greater efficacy of TPO-RA in patients who have undergone a splenectomy? | Mednet